Double-Blind Crossover Trial of Naproxen and Placebo in Patients with Rheumatoid Arthritis
Robert F. Will kens
Abstract
Robert F. Will kens
Abstract
The object of this study was a comparison of the effect of naproxen at the dose of 250 mg bid versus placebo for identical two-week periods in patients with established active rheumatoid arthritis.
OpenAlex reports 14 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The object of this study was a comparison of the effect of naproxen at the dose of 250 mg bid versus placebo for identical two-week periods in patients with established active rheumatoid arthritis.
Key concepts: Medicine, Rheumatoid arthritis, Naproxen, Placebo, Crossover study, Double blind, Arthritis, Internal medicine